Merrimack Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -50.01 | -100% |
| P/S |
|
-315.15 | 33.76 | -1033.59% |
|
|
| P/BV |
|
10.03 | 4.82 | 108.06% |
|
|
| P/FCF |
|
0 | 60.98 | -100% |
|
|
| Ev/Ebitda |
|
-83.66 | -22.12 | 278.19% |
|
|
| Ev/S |
|
-409.09 | 22.56 | -1913.06% |
|
|
| Ev/FCF |
|
-119.61 | 68.75 | -273.98% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.83 | -100% | 13.44 | -100% |
| ROE |
|
-6.3 | 9.61 | -165.58% |
|
|
| ROA |
|
-6.15 | 0.3359 | -1932.33% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
265.39 | -25.17 | -1154.38% |
|
|
| ROCE |
|
-23.21 | 15.33 | -251.42% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0 | -3.67 | -100% | -1.71 | -100% |
| Nеt Debt/Ebitda |
|
2.75 | -3.44 | -180.03% |
|
|
| Debt/Ratio |
|
0 | 0.1972 | -100% |
|
|
| Debt/Equity |
|
0 | 1.54 | -100% |
|
|
| Debt/Net Income |
|
0 | 10.31 | -100% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5496 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.0789 | -100% |
|
|
| DSI |
|
0.5 | 0.2043 | 144.79% |
|
|
| Average dividend growth |
|
-213.75 | 0.0591 | -361991.38% |
|
|
| Average percentage for 5 years |
|
0 | 0.4924 | -100% |
|
|
| Average percentage for payments |
|
29.66 | 43.56 | -31.92% |
|
|
| Difference from average difference in sector |
|
-0.5496 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
0/10
|
-100.93 | -56.89 | 77.41% |
| Growth impulse Ebitda 5 years |
|
-90.9 | -64.81 | 40.26% |
| Growth impulse Net Income 5 years |
|
-94.46 | -58.33 | 61.94% |
| Growth impulse FCF 5 years |
|
-95.15 | -47 | 102.45% |
| Growth impulse EPS 5 years |
|
-94.81 | -32.41 | 192.53% |
IP Score
2.49/10
